奇德新材(300995.SZ):已進入合眾、零跑、比亞迪新能源汽車公司的一級供應商名錄
格隆匯10月12日丨奇德新材(300995.SZ)在投資者互動平台表示,公司產品主要應用於汽車配件功能部件、高端嬰童推車及兒童汽車安全座椅的關鍵結構件、運動器材核心結構件等,其中在汽車及新能源汽車領域,公司與麥格納、延鋒、安道拓等主流汽車零部件企業建立了合作關係,並通過其將產品應用於特斯拉、小鵬、廣汽、平治、豐田、大眾、長城等企業的部分車型上,公司已進入合眾、零跑、比亞迪新能源汽車公司的一級供應商名錄。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.